“We are back to our normal business in non-COVID tests,” Ved Goel, CFO, Dr Lal PathLabs said in an interview with CNBC-TV18.
“People have started coming to labs. Still there is ambiguity but I would say that second half of the year will be better than the first half,” he added.
According to him, since things are changing almost day-to-day, it is a bit difficult to predict how the business will shape up going forward in second half of the year.
About 17 percent of the company’s total revenue came from COVID business during the September quarter.
“Realisation from COVID business is higher compared to non-COVID business. Pricing as well is coming down, hovering around Rs 1,500 on an average for COVID RT-PCR testing,” he said.
“We are very keen to maintain our margins,” Goel said.
Watch video for more
(Edited by : Santosh Nair)
First Published: Nov 9, 2020 5:15 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
